Analysis: Quantum Dot may be sold cheap

Analysts are studying last week's acquisition by Invitrogen of Quantum Dot Corp., the nanotech startup that laid claim to all key life-science applications for quantum dots, trying to guess the sale amount and what it might mean for the industry.

If you want to include this story in your blog, copy and paste this formatted text: